Several cardiovascular risk factors, such as advanced age and smoking history, are prevalent among lung cancer patients at the time of the diagnosis and increase their risk of future heart disease, ...

In this week’s View, Dr. Eagle looks at cardiac rehabilitation for people with heart failure. He then discusses managing cardiovascular (CV) disease in cancer survivors who have completed cancer ...

In this week’s View, Dr. Eagle looks at tighter blood pressure control in patients who are postpartum. He then discusses beta blocker therapy in patients with Takotsubo syndrome. Finally, Dr. Eagle ...

Electrosurgical leaflet laceration and stabilization of the implant (ELASTA-Clip) followed by transapical transcatheter mitral valve replacement (TMVR) is a feasible and less invasive option for ...

Patients with significant tricuspid regurgitation (TR) at intermediate disease stage were more likely to survive at one year when treated via tricuspid transcatheter edge-to-edge-repair (T-TEER) when ...

Cardiovascular care delivered by the Veterans Healthcare Administration (VHA) is equivalent or better than that provided by non-VHA community care, according to a State-of-the-Art Review by the ACC ...

Restricting sodium content in processed foods reduced blood pressure (BP) in one study and using a salt substitute reduced risks of stroke recurrence and death in another study, both published Feb. 5 ...

Additional rhythm-control strategies are frequently continued after index ablation for atrial fibrillation (AFib), according to a study published Feb. 12 in JACC: Clinical Electrophysiology. One in ...

A novel causal machine learning algorithm can determine which patients with atrial fibrillation (AFib) are more likely to benefit from left atrial appendage occlusion (LAAO) compared with ...

In a contemporary population of patients with transthyretin amyloid cardiomyopathy (ATTR-CM) treated with tafamidis, long-term mortality was relatively high, according to a multicenter study published ...

Cardiovascular medications frequently lead the polypharmacy category, often contributing to adverse clinical outcomes, and the most vulnerable among us are often prescribed the most complex regimens.

Two recent case series describe the use of invasive implanted hemodynamic monitoring (IHM) with the CardioMEMS™ HF System (Abbott Laboratories, Abbott Park, Illinois) in pediatric patients. IHM can be ...